title: Effect of gefitinib (ZD1839) on metastatic brain tumour.
authors.forename: Hidenori
authors.initials: H
authors.lastname: Takahashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Ohrui
authors.forename: Satoru
authors.initials: S
authors.lastname: Ebihara
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Yamada
authors.forename: Hidetada
authors.initials: H
authors.lastname: Sasaki
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000627:therapeutic use*; D016879:Salvage Therapy; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D011799:Quinazolines; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib